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Abstract
Background: The scientific literature contains a wealth of information from different
fields on potential disease mechanisms. However, identifying and prioritizing mechan-
isms for further analytical evaluation presents enormous challenges in terms of the
quantity and diversity of published research. The application of data mining approaches
to the literature offers the potential to identify and prioritize mechanisms for more
focused and detailed analysis.
Methods: Here we present MELODI, a literature mining platform that can identify mech-
anistic pathways between any two biomedical concepts.
Results: Two case studies demonstrate the potential uses of MELODI and how it can gen-
erate hypotheses for further investigation. First, an analysis of ETS-related gene ERG and
prostate cancer derives the intermediate transcription factor SP1, recently confirmed to
be physically interacting with ERG. Second, examining the relationship between a new
potential risk factor for pancreatic cancer identifies possible mechanistic insights which
can be studied in vitro.
Conclusions: We have demonstrated the possible applications of MELODI, including two
case studies. MELODI has been implemented as a Python/Django web application, and is
freely available to use at [www.melodi.biocompute.org.uk].
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Introduction
An understanding of the mechanisms that relate identified
risk factors to health outcomes is important in the discov-
ery of potential drug targets and disease biomarkers.
Identifying the mechanistic pathway from a given exposure
to a given disease allows us to consider which steps along
the pathway are potentially modifiable. This offers the po-
tential to identify new biomarkers and potential treatments
to reduce subsequent risk of the disease.
Before embarking on novel research, either in vitro or in
silico, it is important to examine what evidence is already
available, so that the most promising opportunities are pur-
sued and resources are not wasted. However, most scientific
subjects produce too many publications to read in detail,
and consequently researchers often rely on inefficient and
potentially biased methods to prioritize which mechanisms
to investigate. Existing approaches to collating relevant pub-
lished evidence include manual filtering/selection of the lit-
erature, ranking by publication metrics such as impact
factor/number of citations, examining media/social media
reports, and word of mouth. It is clear that a more system-
atic, automated data mining approach offers enormous po-
tential to assist in identification of existing evidence and
therefore prioritization of mechanisms to investigate. To
this end, tools which help us search and refine a set of litera-
ture are becoming increasingly important.
To derive potential mechanisms on the pathway
between two concepts, we can search the literature for
overlapping mechanisms between these two concepts. One
option to do this is to simply search the two concepts
simultaneously with a boolean ‘AND’ operator, using
PubMed [https://www.ncbi.nlm.nih.gov/pubmed] or a
standard search engine. This approach, however, will only
find cases where both concepts are described together in
the same place. This will miss cases where the overlapping
mechanisms are described in independent places, i.e. in one
place in relation to the risk factor and in another in rela-
tion to the outcome. To address this, we need to assess
each concept separately and look for overlapping elements.
Many text mining tools are available which can be used
to extract potential mechanistic terms from the free text of
articles, usually titles and abstracts. A search of OMICtools
(March 2017) produced 104 tools in the ‘Information
Extraction’ category alone [https://omictools.com/informa
tion-extraction-category]. These vary widely in their ap-
proach to key aspects such as synonyms, computational per-
formance and precision (predictive value). Measures of
precision and recall are vital in understanding the effective-
ness of a tool; however, they are hard to measure when
searching for novel mechanisms. An alternative to extracting
information from raw literature text is to use pre-calculated
literature annotation objects. These can either be generated
by humans, e.g. Medical Subject Headings (MeSH) [https://
www.nlm.nih.gov/mesh/] or computationally derived, e.g.
Semantic MEDLINE Database (SemMedDB).1
The MeSH thesaurus is a well-established set of terms
used to index articles from over 5000 of the world’s lead-
ing biomedical journals. These terms are freely provided by
the National Library of Medicine and currently consist of
over 27 000 descriptors, which are used by the MeSH staff
to assign the most appropriate terms to each MEDLINE/
PubMed article. Data are arranged in a complex hierarchy
and are available to download in many different formats
including summary data, hierarchy and frequency.
SemMedDB is a repository of semantic predications ex-
tracted by SemRep2 which uses the Unified Medical
Language System (UMLS) and a set of defined rules. For
every title and abstract, a Subject-PREDICATE-object tri-
ple is generated where the subject and object are terms
from the UMLS Metathesaurus and the predicate is a rela-
tion from the UMLS Semantic Network. For example, the
sentence ‘We used haemofiltration to treat a patient with
digoxin overdose that was complicated by refractory
hyperkalaemia’ produces the following four triples [https://
semrep.nlm.nih.gov/]:
i. Haemofiltration-TREATS-Patient;
ii. Digoxin overdose-PROCESS_OF-Patients;
iii. hyperkalaemia-COMPLICATES-Digoxin overdose;
iv. Haemofiltration-TREATS(INFER)-Digoxin overdose.
Identifying patterns and overlapping elements across
two sets of scientific literature could involve either finding
single terms common to both articles, e.g. MeSH or
SemMedDB terms, or more complex associations, e.g.
Key Messages
• The biomedical literature contains information on potential mechanisms linking risk factors and disease.
• We describe MELODI, a data mining tool to enable potential mechanisms to be derived from the literature.
• MELODI prioritizes known and unknown mechanisms for further detailed investigation.
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finding pairs of SemMedDB triples where the object of a
triple in one article set is the subject of a triple in the other
(Figure 1). This has been attempted by a number of others.
One well-established method is Arrowsmith,3 which is
based on single overlapping words from article titles only,
limited to a maximum of 25 000 articles per article set and
has limited options to download, visualize, filter and ex-
plore the resulting data (Supplementary Table 2, available
as Supplementary data at IJE online). Another application
is TeMMPo [https://www.temmpo.org.uk/] which was de-
veloped for identifying intermediate biological mechanisms
underpinning the effects of lifestyle factors on cancer out-
comes, using a predefined set of possible intermediates.
This approach, however, is hypothesis driven (because
intermediates have to be identified in advance) which lim-
its the capacity to identify novel intermediates. There are
also examples of searching SemMedDB data for overlap-
ping elements4,5 and even proof of principle examples of
using graph databases.6 However, there is currently no
modern software tool to perform this task on custom data
sets in an efficient and intuitive way using the enrichment
of annotation objects to refine the list of terms.
We present MELODI (Mining Enriched Literature
Objects to Derive Intermediates), a web application which
provides a user-friendly environment in which to identify
overlapping intermediates from two sets of articles repre-
senting two distinct biomedical concepts. MELODI in-
cludes an enrichment step, whereby the frequencies of
terms within a set of articles are compared with the
background frequencies in the whole database. This step is
particularly important for identification of overlapping
elements, due to the abundance of common terms and the
error rate associated with extracting terms from free text.
Enrichment prioritizes cases where an object has been
derived from text on multiple separate occasions, and often
these are from independent studies. This reduces the effect
of artificial object enrichment caused by frequent mentions
of a term/phrase in a single abstract and incorrect object
assignment (where an object has been incorrectly ex-
tracted/assigned) based on writing style. MELODI also has
an upper limit on the number of articles per article set of
one million and, via authentication, provides user space
which retains user-specific search results and article sets.
Methods: implementation
Application construction
We constructed MELODI using the Django web frame-
work [https://djangoproject.com] with the following add-
itional plugins and features. Authentication is handled via
the Django Social Authentication plugin [https://django-so
cial-auth.readthedocs.org/en/latest/], providing a method
to make all data, jobs and results both user-specific and re-
trievable. As some of the database queries were proving
too intensive for a responsive user experience, we inte-
grated a task management system. This uses the distributed
task queue Celery [http://www.celeryproject.org/] and the
Figure 1. An overview of the enrichment analysis. An example analysis of two article sets, one with 70 000 articles and one with 100 000 articles. For
each article set, the SemMedDB and MeSH data are retrieved from the graph (open circles) with roughly twice as many objects as articles. An enrich-
ment step identifies those objects that are enriched in that particular data set compared with the background (solid circles and numbers in parenthe-
ses). Those objects that are found to be overlapping between the article sets are returned for further analysis.
International Journal of Epidemiology, 2018, Vol. 47, No. 2 371
Downloaded from https://academic.oup.com/ije/article-abstract/47/2/369/4803214
by University of Bristol Library user
on 17 May 2018
in-memory data structure store Redis [http://redis.io/].
Allowing jobs to be handled by a sophisticated task man-
agement system removes the need to wait on-screen for
analyses to complete and provides the opportunity for
large complex queries. Supplementary Figure 1 (available
as Supplementary data at IJE online) summarizes the flow
of the application.
The graph database
Identifying connections between two sets of articles can in-
volve searching many millions of objects and relationships.
Data storage and analysis of this type are suited to graph
databases, and with recent advances in this field we decided
from the outset to use a graph database [Neo4j, https://
neo4j.com/]. Neo4j is a database constructed of nodes, rela-
tionships and properties, which structures data on the basis
of relationships rather than in a conventional tabular struc-
ture. We chose this approach in preference to a relational
database due to: the data being relationship rich; the pre-
dicted search strategies (i.e. identifying novel relationships
between data sets); and the intuitive nature of using a graph
to contain and search data of this type. We implemented an
additional MySQL database [https://www.mysql.com/] to
provide job progress reports, record user-specific job data
and improve data processing at the front end.
Data
We preloaded the graph database with publicly available
data from MeSH and SemMedDB, and then augmented
and modified with frequencies per year for each annotated
term and user-provided relationship datum (Table 1). As
of March 2017, the graph consists of over 44 million nodes
and 200 million relationships, the main components of
which are listed in Table 2. We will update the graph as
new releases of MeSH and SemMedDB data are released.
Preloaded data
Table 1 lists the sources of data that were preloaded into
the graph, notably summary data from SemMedDB and
MeSH. We first transformed SemMedDB data sets from
SQL and then all data were converted to a standard de-
limited format. We then inserted the data into the graph
using the ‘neo4j-import’ command, a very efficient method
for inserting large amounts of data into a Neo4j graph.
Data needed to be pre-processed to include the same separ-
ator, with correct header information and care taken so
that all other insertion requirements were met. The appli-
cation code, scripts that we used to transform the raw data
into appropriate files and the neo4j import command are
available at [https://github.com/MRCIEU/melodi/]. Once
data were inserted, the graph was indexed in a similar way
to standard relational databases.
Uploaded data
Our main aim of preloading a large amount of data into the
graph was to minimize the time spent processing user-supplied
Table 1. Sources of data
Entry Name Version Description
P MeSH countsa 2015 Frequency counts for main MeSH terms
P MeSH structureb 2016 MeSH hierarchy structure
P PubMedc 26 Basic article data up to 30 April 2016
P PubMed-MeSHc 2016 MeSH terms for each PubMed article
P SemMedDBd 26 SemMedDB summary data for each article
U Article set N/A Collection of PubMed articles
U Article set: PubMed N/A Article set to PubMed relationships
C New PubMed Daily PubMed information not already in database
C PubMed-Mesh Daily PubMed to MeSH relationships
P, preloaded; U, user uploaded; C, computationally uploaded; N/A, not available.
a[https://mbr.nlm.nih.gov/Download/].
b[https://www.nlm.nih.gov/mesh/download_mesh.html].
c[https://mbr.nlm.nih.gov/MRCOC.shtml].
d[http://skr3.nlm.nih.gov/SemMedDB/index.html].
Table 2. Graph details
Data Type Number
PubMed article Node 25698930
MeSH term Node 464122
MeSH tree Node 56326
SemMedDB triple Node 17713740
SemMedDB concept Node 284806
PubMed-MeSH Relationship 80395022
PubMed-SemMedDB triple Relationship 84621296
SemMedDB Triple-SemMedDB concept Relationship 35498324
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information. Therefore, the only modifications to the graph
required when generating a user set of articles are the specifica-
tion of the article set as a node and specification of the relation-
ships between that node and the publications to which it
relates, e.g. the lines connecting the blue ‘Article Set’ node and
the green ‘Publication’ nodes in Supplementary Figure 1. We
initially attempted to create an empty graph that was organic-
ally populated with user information; however, the overheads
associated with dynamically creating a graph using large
amounts of data and using the less efficient insertion methods
were too great.
Using the application
Creating an article set
MELODI is based on identifying mechanisms linking two
article sets. An article set is simply a set of articles that rep-
resent a defined concept, e.g. ‘body mass index’. There are
two ways to create a new article set, each of which is
defined by a set of PubMed IDs. The first is to perform a
PubMed search within the application. This retrieves the
PubMed IDs using the Entrez programming utilities,7 and
populates the graph with the new relationships as
described above. The second option is to upload a set of
PubMed IDs. The benefit of this option is that a set of IDs
can be hand curated, improving the focus of the article set,
removing the reliance on the methodology of a PubMed
search and allowing for greater flexibility in how the set is
created. When carefully constructed, producing article sets
in this way will generate the most informative results with
higher specificity (although this ‘manual curation’ has the
potential to introduce additional bias).
Comparing article sets
A simple hypothesis-free approach to comparing the two
article sets would be to identify terms which overlap across
the two sets and quantify their occurrence using the num-
ber of articles mentioning them. This would identify the
most common elements present in the article sets, but
many of these will be uninformative (e.g. commonly occur-
ring terms). MELODI reduces the problem with a two-step
strategy (Figure 2), using enrichment to identify terms that
Figure 2. Exploring the results. An example of the visualizations and filters within the results. Panel A contains the main filtering options for the
Semantic Medline data, including P-value, odds ratio and predicate frequency rank (PFR). This final metric allows the user to filter results based on
the global frequencies of the SemMedDB predicates, on the assumption that less frequent predicates are more informative. Panel B gives an example
of the force-directed graph visualization of the results. Each article set, subject and object is displayed as a node, with the relationships between them
collapsed into single arcs. The thickness of these arcs represents the number of publications generating the relationship. Panel C represents the
same data in a Sankey diagram. This time the individual predicates are listed in square brackets and the thickness of the bands represents the num-
ber of publications, each SemMed subject and object as a type associated with it. Those present in the figures are listed in panel D. This gives an im-
mediate overview of the types of terms present in the results on display. Panel E shows the table displayed below panels A-D on the results page.
This table is the data source behind the visualizations, and therefore controls what is displayed. Clicking on any of the coloured terms adds that term
to a filter box in panel A, which can then be set to exclude (N) or include (Y) in the results. Panel F shows the detailed publication data from one of
these links, allowing the user to correlate the enriched concepts to the actual articles they were derived from.
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occur in the article sets more often than would occur by
chance.
In the first step, for a given article set the enriched elem-
ents are identified. For MeSH terms, this is based on the
number of times a MeSH term has been annotated as a
main MeSH term in the article set, compared with the fre-
quency of the main MeSH terms across all articles in
MEDLINE (calculated from the entire set of MeSH data).
For SemMedDB, two alternative analysis methods are
available. The first is very similar to the MeSH approach,
using the single SemMedDB terms (extracted from the
triples) and then identifying enriched terms using their pre-
calculated global frequencies. The second has a similar
enrichment step but using the entire triplet and, again, fre-
quencies calculated from the global data set as the refer-
ence. An extra filtering step is also employed for
SemMedDB triples, which restricts the objects of article set
A and the subjects of article set B to terms which are pre-
sent fewer than 150 000 times in the SemMedDB data set.
This vastly reduces the number of overlapping terms,
removing 88 high-level terms such as ‘Patients’ and ‘Cells’
which would otherwise introduce unnecessary noise
(Supplementary Table 1, available as Supplementary data
at IJE online). In all three cases, the frequency of the term
is compared between the article set and the entire literature
set using a two-tailed Fisher’s exact test (FET). P-values
are corrected for multiple testing using the Benjamini/
Hochberg (non-negative) correction with a cutoff of
P< 1e-5. The results (P-value, corrected P-value and odds
ratio) are stored on file for later use to avoid the need for
repeating this step which can be computationally demand-
ing. The enrichment ensures that when large numbers of
articles are involved, multiple instances of a term are
required to define a term as enriched, i.e. a single instance
of a term is unlikely to be sufficient to be marked as en-
riched unless the article set in question is relatively small.
Exploring the results
An analysis of two article sets can be performed using the
MeSH terms and/or the SemMedDB data. The results of
these independent approaches are provided separately for
further investigation. As the analysis is hypothesis free, we
believe it is important to provide a first-pass filtered set of
results on the initial view but also include access to the en-
tire set of results, allowing the user to explore the data in
their entirety. We have provided the following filtering
parameters: FET corrected P-value, FET odds ratio and the
top number of results (all methods), as well as minimum
position in the MeSH hierarchy (MeSH method) and fre-
quency of the predicate term (SemMedDB triple method).
The inclusion of all predicates in the final data is deliber-
ate, as cases where there are low numbers of enriched
overlapping SemMedDB triple objects can still hold valu-
able information but may use more common predicates
such as ASSOCIATED_WITH and AFFECTS. This is un-
like other approaches5 in which a universal predicate filter
was used. As article set comparisons produce differing
numbers of overlapping elements, a basic set of dynamic
filtering rules are employed when displaying the results for
the first time, adjusting the filters based on the number of
results, e.g. low numbers of overlapping enriched elements
are treated with a more relaxed set of parameters.
Visualization of results is provided using interactive
Sankey diagrams and, for SemMedDB triples, an add-
itional force-directed network diagram (Figure 2). Both are
based on the same data displayed in the table on the page,
with strength of supporting evidence represented by the
thickness of connections. The network-based view is often
more intuitive when trying to identify paths between two
article sets, as the same SemMedDB object may be present
multiple times. This view also highlights the possibility of
multiple steps between article sets.
The automatic filtering performed before visualization
attempts to highlight the most informative enriched over-
lapping elements. However, as free text is inherently noisy
(from the automatic language processing point of view)
and computational predictions are not perfect, an add-
itional text filtering option is provided. This consists of a
number of text boxes that can be used either to ‘filter out’
or to ‘restrict to’ keywords within the results, and in the
case of SemMedDB analysis this can be done on any of the
five elements (subject A—predicate 1—[object A/subject B]
—predicate 2—object B) simply by clicking on the corres-
ponding term in the table (Figure 2). The filter option is
particularly useful where there are many overlapping terms
between two article sets, and the restrict option is useful in
cases where a more focused search is required, for example
with defined exposure and outcome terms (Supplementary
Figure 2, available as Supplementary data at IJE online).
Examples of this are discussed later.
The order in which the results are delivered is critical,
as this determines the top set that are displayed for closer
inspection. This order can be based on a number of factors,
e.g. the mean corrected P-value across the two article sets,
the minimum position in the MeSH hierarchy or the predi-
cate frequency rank. In addition to these, a custom-
designed score is used which aims to identify overlapping
elements with a high number of supporting articles in both
article sets (Equation 1), where uniq_a and uniq_b are the
number of unique articles from each article set that contain
the overlapping term. This is based on the assumption that
these elements may be the most reliable, due to many and
equal articles producing the objects. This assumption does
risk ignoring cases where a small number of valid articles
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support one side of the relationship, and should therefore
be used with caution.
Equation 1
score ¼ min ðuniqa;uniqbÞ
max ðuniqa;uniqbÞ
 ðuniqa þ uniqbÞ
Applying MELODI to scientific research
The hypothesis generation methods provided by MELODI
can be applied to a wide range of scientific disciplines. As
we have implemented MELODI using PubMed and
SemMedDB, the current applications have a biomedical
focus. In all cases, the overarching aim would be to derive
intermediates between two clearly defined scientific con-
cepts. These two scientific concepts can arise from a range
of different techniques and approaches, and the intermedi-
ate mechanisms identified can be further investigated using
a similar range of techniques and approaches (Figure 3).
For simplicity, we have grouped some of these approaches
into three categories.
i. Laboratory investigation. There are many ways in
which laboratory studies could result in two concepts
that would benefit from a methodical search of the lit-
erature for mechanisms that may connect them. For
example, a cell line study that identifies differential lev-
els of a particular protein in a treated cancer cell line,
compared with untreated, could be followed up by a
MELODI analysis to identify potential intermediate
proteins. These could then be investigated by further
laboratory analysis, or through literature review.
ii. Epidemiology. Observational epidemiology focuses
on broad ‘exposure’ and ‘outcome’ concepts that
encompass a lot of underlying mechanisms (using co-
hort studies and case-control studies in particular). A
relationship such as that between alcohol intake and
heart disease could be investigated to identify potential
intermediate mechanisms that could be investigated in
the laboratory, as biomarkers or risk predictors in epi-
demiology, or via review of the literature. For causal
analysis in epidemiology, Mendelian randomization
(MR) uses genetic variants as proxies (instruments) to
investigate whether an exposure (such as alcohol in-
take) has a causal effect on disease outcome.8–11
Causal relationships identified with MR could also be
investigated in MELODI (exactly as with conventional
observational studies), but a real advantage of MR is
in following up potential mechanisms identified by
MELODI, to determine whether they are truly on the
causal pathway or are simply biomarkers.
iii. Scientific literature. MELODI is based on the scientific
literature and can very naturally be used to identify po-
tential mechanisms underlying relationships identified
from the literature (particularly those with strong evi-
dence provided by formal systematic review12 and meta-
analysis). The results of a MELODI analysis are also
amenable to literature review for the initial investigation
of a potential mechanism. MELODI provides access to
all the articles that support a particular mechanism, ena-
bling comprehensive manual review to determine
whether the candidate mechanism is plausible. If so, this
may be followed up with a formal systematic review or
meta-analysis, or using laboratory or epidemiological
approaches if additional evidence is needed.
In addition to the approaches described above, an itera-
tive MELODI analysis may be performed, in which an inter-
mediate derived from a MELODI analysis can be used as the
starting point for a new investigation using MELODI.
Results
Performance
We evaluated the time taken for insertion and indexing of all
data. This was completed in under 2 h and produced a graph
database around 50 GB in size, using 80 GB RAM. By pre-
populating the graph with almost all the necessary data, we
greatly reduced the burden of uploading data dynamically.
Extracting large amounts of heavily connected data is still,
however, a challenge. An article set containing 100 000 art-
icles will take around 1 min to create relationships, 2 min for
MeSH enrichment and 5 min for SemMedDB enrichment.
When comparing two article sets of that size, the overlap
step takes 2–5 min, depending on the number of overlapping
elements. Therefore, in total, performing a complete analysis
Figure 3. Concept origins and post-MELODI investigations. MELODI
takes two concepts and derives intermediates. These concepts (solid
lines) can originate from a number of places, e.g. an epidemiological
observation, or a finding from a laboratory experiment. By creating art-
icle sets that represent these two concepts, potential intermediates
(dashed lines) can be derived which may provide testable hypotheses.
These can then be investigated further using approaches similar to
those that created the initial concepts.
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on two large article sets can take around 10 min, depending
on server load and queues. However, as the results of each of
the enrichment steps are stored to disk, they are only per-
formed once. This means that if the same article set is used
for subsequent analysis this step is skipped, reducing compu-
tational requirements by around 80%.
Our inclusion of a task management system allows mul-
tiple users to work with MELODI simultaneously, as jobs
are either added to an available worker or held in a queue
until one becomes available. Currently MELODI is run-
ning on a virtual machine with four central processing
units (CPUs) (and therefore four workers), but can be
scaled easily to support demand by adding more CPUs and
distributing the graph on a cluster.
Case studies
Two case studies describing how MELODI can be used to
generate hypotheses, and how they can be explored, fur-
ther are described below.
ERG and prostate cancer
ETS-related gene (ERG) is an oncogene that has, in the
past decade, become closely linked with prostate cancer.13
Chromosomal rearrangements cause ERG and transmem-
brane protease, serine 2 (TMPRSS2) to fuse together,
forming an oncogenic fusion gene which then disrupts the
ability of stem cells to differentiate into prostate cells, lead-
ing to unregulated and unorganized tissue. This gene fu-
sion is the most common type found in prostate cancer and
can be identified by overexpression of ERG in prostate
carcinomas.14
Much work has been done on elucidating the mechan-
ism by which ERG is associated with prostate cancer. We
used MELODI, therefore, to assess the literature on ERG
and prostate cancer. Article sets for ‘TMPRSS2:ERG or
ETS-related gene’ and ‘prostate cancer’ were generated and
compared (1 March 2017) using 867 and 138 391 articles,
respectively. As expected, many genes previously described
were identified, notably phosphatase and tensin homolog
(PTEN) and androgen receptor (AR) in the SemMedDB
triple results (Table 3, example 1) and ETS Proto-
Oncogene 1 (ETS1), ETS variant 1 (ETV1) and ETS
variant 4 (ETV4) in the SemMedDB single-term results
(Table 3, example 2). In addition, by ordering this latter
set of results by those that share the fewest articles, the Sp1
transcription factor gene (SP1) appears, a transcription fac-
tor known to bind to many promoters with a wide-ranging
set of proposed functions (Figure 4). The SemMedDB data
used to identify this intermediate gene was version 26
which included publication data up to 30 April 2016. In
August 2016, Sharon et al. published a paper describing
the role of SP1 in the regulation of insulin-like growth
Table 3. MELODI result uniform resource locators (URLs)
Example URL
1 [http://melodi.biocompute.org.uk/results/fedb4912-
b04e-4fc8-ac1f-a1c2f04da670/]
2 [http://melodi.biocompute.org.uk/results/2a76380c-
324d-4b47-95e4-2dfcaebc5289/]
3 [http://melodi.biocompute.org.uk/results/2f98cf49-
a084-4ac3-81ff-3d1932d6bb1d/]
4 [http://melodi.biocompute.org.uk/results/1c5edda6-
8fbc-4ea9-b8b6-d66bc82a6a79/]
Figure 4. ERG, SP1 and prostate cancer. The Sankey Plot visualization of the ERG-prostate cancer analysis with SP1 highlighted.
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factor receptor 1 (IGFR1) by the TMPRSS2-ERG fusion
gene.15 In this paper they describe a physical interaction
between the ERG and SP1 transcription factors, identified
by co-immunoprecipitation assays. This work demon-
strates the kind of further investigation that could have
been performed on the basis of identifying SP1 as a poten-
tial intermediate. and confirms the value of MELODI in
identifying novel intermediates.
In addition, the seven articles supporting the connection
between ERG and SP1 are from 2007 and earlier, suggest-
ing that the previous studies of Ewing’s sarcoma and acute
myeloid leukaemia, and not prostate cancer, may have
been overlooked. This indicates that the connection be-
tween ERG, SP1 and prostate cancer could have been iden-
tified many years ago. This can be demonstrated by
running the same analysis but using publications up to and
including 2005, which still finds SP1 as enriched and over-
lapping (Table 3, example 3).
Carnitine and pancreatic cancer
The following example illustrates the utility of MELODI
in the dissection of causal pathways. Using Mendelian ran-
domization (MR), we have recently found that elevated
levels of the amino acid derivative, carnitine, are associated
with an increased risk of developing pancreatic cancer
(unpublished work at the time of article press). In this situ-
ation, MELODI can be used as a starting point to investi-
gate how the exposure and the outcome might be
connected. Our aim was to generate mechanistic hypothe-
ses that might explain how carnitine increases the risk of
pancreatic cancer, for further investigation using in vitro
studies in the laboratory.
Article sets for ‘carnitine’ and ‘pancreatic cancer’ were
created with 14 631 and 82 226 articles, respectively, and
the intermediates derived (Table 3, example 4). Figure 5
shows the enriched relationships identified between these
two sets of data, and highlights possible intermediates be-
tween them. Of interest were the intermediates ‘fatty acid
oxidation’ and ‘insulin’. Upon investigation of the litera-
ture underpinning these connections (this can be done eas-
ily in MELODI which links directly to the articles in
PubMed), we found that carnitine can increase fatty acid
oxidation.16–18 Metabolic reprogramming is a known fea-
ture of cancer cells,19 and fatty acid oxidation can be used
by cancer cells for energy generation.20 We can therefore
generate the following hypothesis for further investigation
in the laboratory: ‘‘carnitine increases fatty acid oxidation
which provides pancreatic cancer cells with a metabolic
advantage’.
Insulin is also a highlighted intermediate linking carni-
tine and pancreatic cancer. Upon investigation of the litera-
ture underpinning the connections, we find that insulin
treatment of skeletal muscle increases the expression of the
carnitine transporter protein OCTN2. Investigation of the
literature highlighted by MELODI informs us that
increased insulin secretion is associated with some forms of
Figure 5. Carnitine and pancreatic cancer. In this example two article sets were compared, one focused around ‘Carnitine’ and the other around
‘Pancreatic Cancer’, the results of which are displayed using a force-directed graph. Each article set (large nodes), subject and object (small nodes) is
displayed as a node, with the relationships between them collapsed into single arcs. The thickness of these arcs represents the number of publica-
tions generating the relationship.
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pancreatic cancer.21 In addition, we have also found using
MR that elevated fasting levels of insulin are causally asso-
ciated with pancreatic cancer (unpublished data at time of
article press). Therefore, with information from MELODI
and our own MR investigations, we can generate the fol-
lowing hypothesis for further investigation in the labora-
tory: ‘elevated levels of insulin cause pancreatic cancer in
part through increased expression of the carnitine trans-
porter in pancreatic cancer cells’. This demonstrates the
power of MELODI as a hypothesis generator to investigate
the mechanisms underlying causal relationships.
Limitations
When identifying single overlapping terms, the structure of
the text is not so important; however, the SemMedDB triple
data are dependent on the structure. For example, an article
set might contain the triples geneA-ASSOCIATED_WITH-
geneB and geneB-ASSOCIATED_WITH-geneA. The under-
lying directionality provided by SemMedDB will lead to
these two triples being treated as separate entities. There are
cases where predicates imply direction, e.g. INHIBITS and
STIMULATES require this restriction, but other predicates
such as PART_OF and ASSOCIATED_WITH might not.
This highlights how the structure of titles and abstracts are
key to the extraction of SemMedDB triples and ultimately
the identification of overlapping terms. In addition, the
assumed directionality from article set A to article set B, and
the method for the identification of overlapping
SemMedDB triples, will likely miss many intermediates.
However, the potential gain of a small number of true-
positives is not worth the increase in false-negatives that
would occur if this restriction was removed. This depend-
ence on a rigid rule-based approach to data extraction could
be alleviated with the inclusion of more sophisticated meth-
ods, such as machine learning or natural language process-
ing. Their absence from MELODI is simply due to a lack of
methods and resources available at the time with which one
could process a large data set such as MEDLINE and ex-
tract complex data structures such as object-predicate-
subject. SemRep and SemMedDB are well-developed tools
that are under active development and provide frequent
data releases. In the future, additional types of data ex-
tracted from articles can be simply added as extra nodes
and relationships to the graph and as additional analysis
methods.
An important limitation of any literature-based tool is
that the published literature may be a biased subset, or a
biased over-representation, of research that has been
undertaken. A large proportion of negative findings are
never published, and groups often publish many related
papers with similar ideas discussed in the abstract. In
addition, the algorithms used to produce the SemMedDB
data and the humans used to assign the MeSH terms may
introduce unconscious bias. Using more flexible agnostic
methods such as those mentioned above would enable the
use of other publicly available data sets, alleviating some
of the bias associated with published literature. Even so,
MELODI is always going to give a biased representation of
what is really known about a topic. However, the alterna-
tive to a computational approach is manual curation,
which is impossible at this scale and potentially prone to
much greater bias. As long as the caveats and limitations
are understood, then the output of this kind of approach
can still be valuable and provide reliable hypotheses.
Discussion
MELODI is a hypothesis-free application that derives
mechanisms, both known and novel, from the published
literature. It uses a graph database to find enriched rela-
tionships between two sets of articles from the entire col-
lection of MEDLINE articles, using both the manually
curated MeSH terms and computationally derived
SemMedDB terms. We have demonstrated its ability to de-
rive both known and unknown intermediates across large
complex data sets. Our examples have shown how it can
derive novel intermediates for new studies and generate
mechanistic targets underlying observed epidemiological
associations.
An additional advantage of this kind of approach is the
inclusion of data from any MEDLINE article, regardless of
impact factor or citation number, which has obvious bene-
fits for the low-impact paper. Often in the course of a sci-
entific investigation, a decision is made to publish when
further work could still be carried out, but time or finan-
cial constraints are overriding. This has the benefit of
releasing information and data early even if the findings
and hypotheses have not been validated. The authors of
such papers may feel that more could have been done and
the resulting work may lack impact; however, tools like
MELODI can still use the output from these papers and,
combined with similar findings, can be used to encourage
others to continue this avenue of research, rather than the
article being lost in the deluge of papers published every
day.
MELODI is already capable of deriving reliable inter-
mediate hypotheses. There is, however, potential for future
development. The graph database is suited very well to the
inclusion of complementary data sets, and the addition of
these is planned. They include drug targets, metabolic
pathways and protein-protein interactions. These extra
data would permit reliable multi-step connections between
article sets using known data connections. The database
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already contains information on the SemMedDB term
types, which provides the necessary connections to the
extra data and further filtering options, e.g. to show only
intermediates that are genes, druggable, proteins, etc.
Filtering of the overlapping elements between article
sets could also be improved with more computational
methods. Machine learning techniques could be applied to
train the filtering steps to improve the accuracy and useful-
ness of intermediates, by learning from user filtering and
overlap with well-established data sets.
Supplementary Data
Supplementary data are available at IJE online.
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